arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Polyrizon Ltd.

PLRZ

$11.15 ▼ -0.35 (-3.04%) at close

5 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Polyrizon Ltd. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $7.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -23.5% ↘

FCF / Share $-6.67

Trailing P/E 2.3x

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-3.33M

↓ -115.9% —

FCF / Share Free cash flow per share

$-6.67

↓ -2420.1% —

Health Breakdown

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
EPS Growth YoY (%)	-99.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	268300.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-115.9% Weak ↓ Weak Declining Year-over-year change in net income	-157.5% Weak Weak Year-over-year change in net income	23.0% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	69.6% Excellent Excellent Year-over-year change in free cash flow	—	—
EPS CAGR 3Y (%)	101.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
FCF / Net Income (x)	1.36x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.46x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Return on Invested Capital (%)	-23.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	262.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	78.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-29.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-113.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-29.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	—	86.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+477%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Net Debt (USD)	$-1.31M	$-2.55M	$-4.00K	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Basic EPS, GAAP (USD)	$4.90	$805.20	$0.30	$0.60	—
Free Cash Flow per Share (USD)	$-6.67	—	$-0.26	$-0.87	—
Book Value per Share (USD)	$13.05	—	$-0.07	$-0.69	—
Tangible Book Value per Share (USD)	$11.47	—	$-0.07	$-0.69	—
Basic Weighted Avg Shares (shares)	680,380	1,994	2.03M	1.31M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Working Capital (USD)	$12.42M	$2.39M	$-448.00K	—	—
Total Equity (USD)	$20.99M	$5.29M	$-191.00K	$-900.00K	$-251.00K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Depreciation Expense (USD)	$342.00K	$118.00K	$4.00K	$5.00K	—
Net Income, GAAP (USD)	$-3.33M	$-1.54M	$-600.00K	$-779.00K	—
Operating Cash Flow (USD)	$-4.53M	$-1.15M	$-537.00K	$-1.13M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 5 quarters

Polyrizon Ltd.

Analytical Summary

5-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare PLRZ with peers